News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Risk of stent infection low, but may be underreported
- Author:
- Ted Bosworth
The systematic review of coronary stent infections leads investigator to question whether they are underreported.
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
In weighing PCI vs. CABG for left main disease, diabetes matters
- Author:
- Ted Bosworth
In patients with diabetes and left main artery disease, the risks of PCI and CABG are different when either can be used.
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Drinking beet juice tied to reduced post-PCI restenosis
- Author:
- Ted Bosworth
Dietary nitrate in the form of beet juice reduced restenosis after percutaneous interventions in a randomized trial.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Woman_Doctor_Computer_Tablet_web.jpg)
New tool better estimates cardiovascular risk in people with lupus
- Author:
- Ted Bosworth
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Eder_Lihi_CANADA_2_web_0.png)
PsA prediction tool approaches clinical utility
- Author:
- Ted Bosworth
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.
News
Two biomarkers identify high-risk lupus nephritis
- Author:
- Ted Bosworth
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.
News
Biosimilars perform identically to originator biologics in natural experiment
- Author:
- Ted Bosworth
A real-world analysis of the impact of biosimilar switches over 3 years of follow-up addresses the limitations of formal trials in assessing...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Psoriasis_forearm_web.jpg)
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
- Author:
- Ted Bosworth
A large population analysis implicates PCSK9 as a target in prevention of psoriasis.
News
After PCI, 1-month beats 12-month DAPT in high-risk patients
- Author:
- Ted Bosworth
When dual was replaced by single antiplatelet therapy 1 month after PCI in Japanese patients, bleeding risk declined.
News
Study supports banning probiotics from the ICU
- Author:
- Ted Bosworth
The risk is particularly acute for powdered formulations, presumably because powder more easily disseminates to contaminate central venous...
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Sham-controlled renal denervation trial for hypertension is a near miss
- Author:
- Ted Bosworth
The SPYRAL HTN–ON MED trial missed its primary endpoint, likely caused in part by imbalances in medication use.
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
First-line AFib ablation cuts risk of progression vs. drug therapy
- Author:
- Ted Bosworth
Atrial fibrillation treated with ablation rather than drug therapy was less likely to progress to persistent symptoms in the PROGRESSIVE-AF trial...
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
If a saphenous graft is available, treat limb threatening ischemia surgically
- Author:
- Ted Bosworth
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Precision CAD testing shows 70% cut in composite risk at 1 year
- Author:
- Ted Bosworth
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
News
In CABG, radial artery works best for second key graft: RAPCO at 15 years
- Author:
- Ted Bosworth
With more than 15 years of follow-up, the radial artery beats other options for the second key coronary target in coronary artery bypass surgery...